# RETACRIT

NDC: 0069-1306
Generic name: epoetin alfa-epbx
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20180618

FDA application: BLA125545

## Active ingredients

- EPOETIN: 3000 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-1306"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-1306
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3af26b0d-8ad0-44e1-a538-8bdb5ab39374